MYCN is recruited to the RASSF1A promoter but is not critical for DNA hypermethylation in neuroblastoma
- 31 December 2012
- journal article
- research article
- Published by Wiley in Molecular Carcinogenesis
- Vol. 53 (5) , 413-420
Abstract
Tumor suppressor genes such as RASSF1A are often epigenetically repressed by DNA hypermethylation in neuroblastoma, where the MYCN proto‐oncogene is frequently amplified. MYC has been shown to associate with DNA methyltransferases, thereby inducing transcriptional repression of target genes, which suggested that MYCN might play a similar mechanistic role in the hypermethylation of tumor suppressor genes in neuroblastoma. This study tested that hypothesis by using co‐immunoprecipitation and ChIP to investigate MYCN–DNA methyltransferase interactions, together with MYCN knock‐down and over‐expression systems to examine the effect of MYCN expression changes on gene methylation, employing both candidate gene and genome‐wide assays. We show that MYCN interacts with DNA methyltransferases and is recruited to the promoter region of RASSF1A. However, using four model systems, we showed that long‐term silencing of MYCN induces only a small loss of DNA methylation at the RASSF1A promoter in MYCN amplified neuroblastoma cell lines and over‐expression of MYCN does not induce any DNA methylation, suggesting that MYCN is not critical for DNA hypermethylation in neuroblastoma.Keywords
Funding Information
- Fonds National de la Recherche (FNR) Luxembourg
- CLIC Sargent UK
- Kidney Research UK (RP42/2009)
- University of Bristol Cancer Research Fund
This publication has 44 references indexed in Scilit:
- The RASSF gene family members RASSF5, RASSF6 and RASSF7 show frequent DNA methylation in neuroblastomaMolecular Cancer, 2012
- Transcriptional Repression: The Dark Side of MycGenes & Cancer, 2010
- The Arf tumor suppressor protein inhibits Miz1 to suppress cell adhesion and induce apoptosisJournal of Cell Biology, 2010
- MYCN-regulated microRNAs repress estrogen receptor-α ( ESR1 ) expression and neuronal differentiation in human neuroblastomaProceedings of the National Academy of Sciences, 2010
- Epigenetic Silencing of the RASSF1A Tumor Suppressor Gene through HOXB3-Mediated Induction of DNMT3B ExpressionMolecular Cell, 2009
- Clusterin, a Haploinsufficient Tumor Suppressor Gene in NeuroblastomasJNCI: Journal of the National Cancer Institute, 2009
- N-Myc Regulates a Widespread Euchromatic Program in the Human Genome Partially Independent of Its Role as a Classical Transcription FactorCancer Research, 2008
- Distinct transcriptional MYCN/c-MYC activities are associated with spontaneous regression or malignant progression in neuroblastomasGenome Biology, 2008
- High Myc pathway activity and low stage of neuronal differentiation associate with poor outcome in neuroblastomaProceedings of the National Academy of Sciences, 2008
- Myc influences global chromatin structureThe EMBO Journal, 2006